ZFR2
gene geneOn this page
Summary
ZFR2 (zinc finger RNA binding protein 2, HGNC:29189) is a protein-coding gene on chromosome 19p13.3, encoding Zinc finger RNA-binding protein 2 (Q9UPR6).
Predicted to enable double-stranded RNA binding activity and single-stranded RNA binding activity.
Source: NCBI Gene 23217 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 256 total
- MANE Select transcript:
NM_015174
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29189 |
| Approved symbol | ZFR2 |
| Name | zinc finger RNA binding protein 2 |
| Location | 19p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000105278 |
| Ensembl biotype | protein_coding |
| OMIM | 619284 |
| Entrez | 23217 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 6 protein_coding, 3 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000262961, ENST00000438164, ENST00000439086, ENST00000586578, ENST00000587212, ENST00000591712, ENST00000591965, ENST00000592398, ENST00000592807, ENST00000674260, ENST00000938272
RefSeq mRNA: 2 — MANE Select: NM_015174
NM_001145640, NM_015174
CCDS: CCDS45921, CCDS45922
Canonical transcript exons
ENST00000262961 — 19 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000664147 | 3831660 | 3831878 |
| ENSE00000664149 | 3831303 | 3831556 |
| ENSE00000664155 | 3827471 | 3827653 |
| ENSE00000664167 | 3825230 | 3825407 |
| ENSE00001597506 | 3804024 | 3806125 |
| ENSE00001603270 | 3807172 | 3807269 |
| ENSE00001609789 | 3821340 | 3821479 |
| ENSE00001637716 | 3813820 | 3813958 |
| ENSE00001653356 | 3810750 | 3810845 |
| ENSE00001655567 | 3816674 | 3816845 |
| ENSE00001785557 | 3808872 | 3808983 |
| ENSE00001786015 | 3820182 | 3820290 |
| ENSE00001791467 | 3811272 | 3811366 |
| ENSE00001793228 | 3819045 | 3819235 |
| ENSE00003535190 | 3823246 | 3823403 |
| ENSE00003576352 | 3834773 | 3834983 |
| ENSE00003611226 | 3833664 | 3833778 |
| ENSE00003624304 | 3822081 | 3822200 |
| ENSE00003845290 | 3868965 | 3869038 |
Expression profiles
Bgee: expression breadth ubiquitous, 175 present calls, max score 93.00.
FANTOM5 (CAGE): breadth broad, TPM avg 2.7146 / max 77.5798, expressed in 333 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 178341 | 2.6123 | 329 |
| 178342 | 0.1023 | 65 |
Top tissues by expression
276 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pituitary gland | UBERON:0000007 | 93.00 | gold quality |
| adenohypophysis | UBERON:0002196 | 92.73 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 88.66 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 87.21 | gold quality |
| right testis | UBERON:0004534 | 86.82 | gold quality |
| left testis | UBERON:0004533 | 86.58 | gold quality |
| right frontal lobe | UBERON:0002810 | 86.34 | gold quality |
| primary visual cortex | UBERON:0002436 | 85.75 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.68 | gold quality |
| cingulate cortex | UBERON:0003027 | 84.66 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 84.56 | gold quality |
| testis | UBERON:0000473 | 84.12 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 83.77 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 83.71 | gold quality |
| nucleus accumbens | UBERON:0001882 | 83.39 | gold quality |
| endothelial cell | CL:0000115 | 83.20 | gold quality |
| cortical plate | UBERON:0005343 | 83.05 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 82.32 | gold quality |
| retina | UBERON:0000966 | 82.30 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.90 | gold quality |
| amygdala | UBERON:0001876 | 81.52 | gold quality |
| hypothalamus | UBERON:0001898 | 81.19 | gold quality |
| neocortex | UBERON:0001950 | 80.39 | gold quality |
| forebrain | UBERON:0001890 | 80.31 | gold quality |
| cerebral cortex | UBERON:0000956 | 80.19 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 79.60 | gold quality |
| occipital lobe | UBERON:0002021 | 79.56 | gold quality |
| sperm | CL:0000019 | 79.44 | silver quality |
| telencephalon | UBERON:0001893 | 79.27 | gold quality |
| adult organism | UBERON:0007023 | 79.24 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.72 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
55 targeting ZFR2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-3686 | 99.90 | 70.53 | 2432 |
| HSA-MIR-124-3P | 99.89 | 73.74 | 3043 |
| HSA-MIR-506-3P | 99.89 | 73.55 | 3057 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-4503 | 99.85 | 71.45 | 1869 |
| HSA-MIR-6842-5P | 99.80 | 67.54 | 1587 |
| HSA-MIR-7110-5P | 99.80 | 67.84 | 1712 |
| HSA-MIR-92A-2-5P | 99.75 | 67.01 | 2164 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-378G | 99.71 | 64.90 | 1106 |
| HSA-MIR-6752-5P | 99.59 | 67.32 | 1243 |
| HSA-MIR-762 | 99.58 | 66.61 | 1994 |
| HSA-MIR-4472 | 99.56 | 66.08 | 1478 |
| HSA-MIR-6751-5P | 99.56 | 64.99 | 1145 |
| HSA-MIR-4437 | 99.52 | 65.29 | 1266 |
| HSA-MIR-186-3P | 99.51 | 66.24 | 1685 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-12131 | 99.48 | 68.72 | 1673 |
| HSA-MIR-4498 | 99.47 | 67.42 | 2360 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
Cross-species orthologs
8 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zfr2 | ENSDARG00000071683 |
| mus_musculus | Zfr2 | ENSMUSG00000034949 |
| rattus_norvegicus | Zfr2 | ENSRNOG00000020416 |
| drosophila_melanogaster | loqs | FBGN0032515 |
| drosophila_melanogaster | CG12493 | FBGN0035571 |
| drosophila_melanogaster | blanks | FBGN0035608 |
| drosophila_melanogaster | Zn72D | FBGN0263603 |
| caenorhabditis_elegans | zfr-1 | WBGENE00022388 |
Paralogs (14): STAU2 (ENSG00000040341), ZFR (ENSG00000056097), ADAT1 (ENSG00000065457), STAU1 (ENSG00000124214), ILF3 (ENSG00000129351), TARBP2 (ENSG00000139546), ADAD2 (ENSG00000140955), ILF2 (ENSG00000143621), ADAR (ENSG00000160710), ADAD1 (ENSG00000164113), STRBP (ENSG00000165209), PRKRA (ENSG00000180228), ADARB2 (ENSG00000185736), ADARB1 (ENSG00000197381)
Protein
Protein identifiers
Zinc finger RNA-binding protein 2 — Q9UPR6 (reviewed: Q9UPR6)
All UniProt accessions (5): Q9UPR6, A0A6I8PRF6, K7EKD7, K7EPY6, K7EQC0
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9UPR6-1 | 1 | yes |
| Q9UPR6-2 | 2 | |
| Q9UPR6-3 | 3 |
RefSeq proteins (2): NP_001139112, NP_055989* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003604 | Matrin/U1-like-C_Znf_C2H2 | Domain |
| IPR006561 | DZF_dom | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR043519 | NT_sf | Homologous_superfamily |
| IPR049401 | DZF_dom_N | Domain |
| IPR049402 | DZF_dom_C | Domain |
Pfam: PF07528, PF12874, PF20965
UniProt features (27 total): region of interest 8, sequence variant 7, compositionally biased region 4, splice variant 4, chain 1, domain 1, coiled-coil region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UPR6-F1 | 64.88 | 0.32 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 106 (showing top):
MULLIGHAN_NPM1_SIGNATURE_3_UP, TSENG_IRS1_TARGETS_DN, SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS, chr19p13, GOMF_SINGLE_STRANDED_RNA_BINDING, MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP, KOYAMA_SEMA3B_TARGETS_DN, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, E2F1_UP.V1_DN, PGF_UP.V1_DN, ATF2_S_UP.V1_UP, ATF2_UP.V1_UP, SALL4_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (4): double-stranded RNA binding (GO:0003725), single-stranded RNA binding (GO:0003727), zinc ion binding (GO:0008270), nucleic acid binding (GO:0003676)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA binding | 2 |
| transition metal ion binding | 1 |
| binding | 1 |
Protein interactions and networks
STRING
502 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZFR2 | RBM7 | Q9Y580 | 446 |
| ZFR2 | FUS | P35637 | 426 |
| ZFR2 | ZNF169 | Q14929 | 402 |
| ZFR2 | NANOS2 | P60321 | 401 |
| ZFR2 | ZFP36L1 | Q07352 | 397 |
| ZFR2 | ZFR | Q96KR1 | 384 |
| ZFR2 | ENTPD6 | O75354 | 370 |
| ZFR2 | PDGFC | Q9NRA1 | 358 |
| ZFR2 | PTPN14 | Q15678 | 355 |
| ZFR2 | ENG | P17813 | 338 |
| ZFR2 | VEGFB | P49765 | 334 |
| ZFR2 | ZFP36 | P26651 | 330 |
| ZFR2 | SPATC1 | Q76KD6 | 329 |
| ZFR2 | NMRK2 | Q9NPI5 | 329 |
| ZFR2 | FAM169A | Q9Y6X4 | 325 |
IntAct
1 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| AP3B1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (5): ILF2 (Co-fractionation), ZFR2 (Co-fractionation), ZFR2 (Affinity Capture-MS), ZFR2 (Protein-RNA), ZFR2 (Affinity Capture-MS)
ESM2 similar proteins: A0JPN4, A1YF56, A2A288, A2A9T0, A2AEV7, A6QQJ8, A7MCY6, A8MVW0, D3ZG83, D3ZZN9, O09039, O15037, O75427, O94983, O95382, O95947, P0C5W1, P98077, Q02779, Q16584, Q2M3V2, Q53LP3, Q5D1E7, Q5D1E8, Q66HA1, Q66K74, Q66L42, Q6DG50, Q6ZUM4, Q6ZW31, Q76KP1, Q7T0L4, Q7TSG2, Q80XI6, Q80Y50, Q8BIY3, Q8BLS7, Q8K120, Q8K1S6, Q8R5G7
Diamond homologs: O88532, Q08E27, Q0VD35, Q12906, Q562A2, Q5R6Y5, Q5REX3, Q5U231, Q5ZIL4, Q6DCD0, Q6DD04, Q6GL57, Q6GPM1, Q6NXA4, Q6PCR6, Q7TP98, Q91550, Q91WM1, Q96KR1, Q96SI9, Q9H898, Q9JIL3, Q9JKU6, Q9UPR6, Q9Z1X4, B8GAM6, P51400, P78563, P97616, Q12905, Q5RFJ1, Q6NZ06, Q6P8G1, Q7ZW47, Q8CJ67, Q91ZS8, Q9CXY6, Q9JI20, Q9NII1, Q9NS39
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
256 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 219 |
| Likely benign | 26 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4303 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:3807292:A:T | acceptor_gain | 1.0000 |
| 19:3810744:CCTTA:C | donor_loss | 1.0000 |
| 19:3810745:CTTA:C | donor_loss | 1.0000 |
| 19:3810746:TTACC:T | donor_loss | 1.0000 |
| 19:3810747:TACCC:T | donor_loss | 1.0000 |
| 19:3810748:A:AT | donor_loss | 1.0000 |
| 19:3813814:CCGCA:C | donor_loss | 1.0000 |
| 19:3813815:CGCA:C | donor_loss | 1.0000 |
| 19:3813816:GCACC:G | donor_loss | 1.0000 |
| 19:3813817:CACCT:C | donor_loss | 1.0000 |
| 19:3813818:A:AT | donor_loss | 1.0000 |
| 19:3813819:C:CA | donor_loss | 1.0000 |
| 19:3813955:CCAT:C | acceptor_gain | 1.0000 |
| 19:3813956:CATC:C | acceptor_gain | 1.0000 |
| 19:3813957:ATCT:A | acceptor_loss | 1.0000 |
| 19:3816670:TTAC:T | donor_loss | 1.0000 |
| 19:3816672:A:AC | donor_gain | 1.0000 |
| 19:3816673:C:CC | donor_gain | 1.0000 |
| 19:3816841:CGCTG:C | acceptor_gain | 1.0000 |
| 19:3816843:CTG:C | acceptor_gain | 1.0000 |
| 19:3816844:TG:T | acceptor_gain | 1.0000 |
| 19:3818899:T:TA | donor_gain | 1.0000 |
| 19:3819063:T:TA | donor_gain | 1.0000 |
| 19:3819231:CCGGG:C | acceptor_gain | 1.0000 |
| 19:3819232:CGGG:C | acceptor_gain | 1.0000 |
| 19:3819232:CGGGC:C | acceptor_gain | 1.0000 |
| 19:3819236:C:CC | acceptor_gain | 1.0000 |
| 19:3820178:CTA:C | donor_loss | 1.0000 |
| 19:3820179:TA:T | donor_loss | 1.0000 |
| 19:3820180:A:C | donor_loss | 1.0000 |
AlphaMissense
6010 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:3806102:G:C | F889L | 0.998 |
| 19:3806102:G:T | F889L | 0.998 |
| 19:3806104:A:G | F889L | 0.998 |
| 19:3822098:G:C | H492D | 0.997 |
| 19:3822154:C:G | C473S | 0.997 |
| 19:3822154:C:T | C473Y | 0.997 |
| 19:3822155:A:T | C473S | 0.997 |
| 19:3822163:C:T | C470Y | 0.997 |
| 19:3827639:A:C | H289Q | 0.997 |
| 19:3827639:A:T | H289Q | 0.997 |
| 19:3822086:A:C | Y496D | 0.996 |
| 19:3822162:G:C | C470W | 0.996 |
| 19:3822163:C:G | C470S | 0.996 |
| 19:3822164:A:T | C470S | 0.996 |
| 19:3822168:G:C | F468L | 0.996 |
| 19:3822168:G:T | F468L | 0.996 |
| 19:3822170:A:G | F468L | 0.996 |
| 19:3831328:C:G | C276S | 0.996 |
| 19:3831328:C:T | C276Y | 0.996 |
| 19:3831329:A:T | C276S | 0.996 |
| 19:3822098:G:T | H492N | 0.995 |
| 19:3822116:G:C | H486D | 0.995 |
| 19:3822154:C:A | C473F | 0.995 |
| 19:3822155:A:G | C473R | 0.995 |
| 19:3822163:C:A | C470F | 0.995 |
| 19:3827535:C:G | C324S | 0.995 |
| 19:3827536:A:T | C324S | 0.995 |
| 19:3827623:G:C | H295D | 0.995 |
| 19:3827641:G:C | H289D | 0.995 |
| 19:3827641:G:T | H289N | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000021375 (19:3853847 T>C), RS1000135816 (19:3838088 C>A,T), RS1000170926 (19:3819432 A>C), RS1000280143 (19:3814687 G>A,C), RS1000341076 (19:3846548 C>T), RS1000474065 (19:3839077 G>A), RS1000593288 (19:3804265 G>A), RS1000626269 (19:3819706 G>A), RS1000713917 (19:3838864 G>A), RS1000733248 (19:3824363 A>T), RS1000795746 (19:3846802 C>T), RS1000832838 (19:3807571 G>A), RS1000873130 (19:3859716 A>G), RS1000885478 (19:3842629 T>G), RS1000930271 (19:3808425 G>A,T)
Disease associations
OMIM: gene MIM:619284 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007637_40 | Diffusing capacity of carbon monoxide | 6.000000e-06 |
| GCST008129_61 | Body mass index | 2.000000e-07 |
| GCST008513_34 | Health literacy | 4.000000e-06 |
| GCST012489_82 | Heel bone mineral density x serum urate levels interaction | 6.000000e-09 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009369 | diffusing capacity of the lung for carbon monoxide |
| EFO:0004340 | body mass index |
| EFO:0010104 | health literacy measurement |
| EFO:0004531 | urate measurement |
| EFO:0009270 | heel bone mineral density |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, increases methylation, decreases methylation, increases expression | 2 |
| Benzo(a)pyrene | affects methylation | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Valproic Acid | increases methylation, decreases expression | 2 |
| p-Chloromercuribenzoic Acid | affects cotreatment, decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| bisphenol S | increases methylation | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Arsenic | affects methylation | 1 |
| Carbamazepine | affects expression | 1 |
| Estradiol | increases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Rotenone | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Aflatoxin B1 | affects methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.